Enhance MD vs WeightWatchers (Sequence): Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Enhance MD beats WeightWatchers (Sequence) overall, scoring 7.8/10 vs 7.4/10. Enhance MD is more affordable at $212/mo vs $423/mo. Choose Enhance MD for budget-conscious users interested in combination therapies. Choose WeightWatchers (Sequence) for users who want glp-1 medication combined with the weightwatc.
A side-by-side comparison of Enhance MD and WeightWatchers (Sequence) covering pricing, scores, medication types, insurance, and more to help you decide.
Enhance MD
#18 of 48Affordable telehealth provider offering both compounded and brand-name GLP-1 medications with combination therapy options.
Visit Enhance MDWeightWatchers (Sequence)
#29 of 48WeightWatchers' clinical weight management arm (acquired from Sequence). Membership is tiered: 12-month plan first month $149-$299 depending on tier, then $74/mo ongoing for months 2-12; shorter plans are higher per-month. Medication billed separately: $199/mo intro for 2 months, then $349/mo ongoing. Lineup includes Saxenda (liraglutide brand), Wegovy, Zepbound, and compounded semaglutide/tirzepatide.
Visit WeightWatchers (Sequence)| Feature | Enhance MD | WeightWatchers (Sequence) |
|---|---|---|
| Our Score | 7.8/10 | 7.4/10 |
| Starting Price | $212/mo | $423/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | Yes |
| Best For | Budget-conscious users interested in combination therapies | Users who want GLP-1 medication combined with the WeightWatchers program and community — $74 ongoing membership (on 12-month plan, $149-$299 first month) + $349 ongoing medication = $423/mo all-in |
| Ranking | #18 | #29 |
Pros & Cons Compared
Enhance MD
Pros
- +$115/mo starting price with access to both brand-name and compounded — rare at this price point
- +Offers combination therapies (GLP-1 + B12, GLP-1 + NAD+) for patients wanting enhanced protocols
- +Quick asynchronous consultations — most patients approved within 24 hours without video calls
- +Flexible dosing: can start at lower doses than standard protocols for sensitive patients
Cons
- −Lighter clinical support than higher-priced platforms — check-ins are patient-initiated, not scheduled
- −No insurance billing and limited customer support hours (business days only, no weekends)
WeightWatchers (Sequence)
Pros
- +Combines GLP-1 medication with WeightWatchers' proven points system and community support
- +Insurance accepted for medication — can reduce costs significantly with qualifying plans
- +Decades of brand trust and weight loss expertise applied to clinical medication management
- +Access to WW community, workshops, and digital tools alongside medication
Cons
- −$269/mo without insurance is expensive for what's included clinically
- −The WW program integration adds complexity that medication-only users won't value
- −The Sequence acquisition is still integrating — some operational inconsistencies remain
- −Less medication flexibility than pure-play GLP-1 platforms
Our Verdict
Enhance MD edges out WeightWatchers (Sequence) with a score of 7.8/10 vs 7.4/10. If budget is your priority, Enhance MD starts at $212/mo compared to WeightWatchers (Sequence)'s $423/mo. WeightWatchers (Sequence) accepts insurance, which can significantly reduce your out-of-pocket costs. Choose Enhance MD if you want: budget-conscious users interested in combination therapies. Choose WeightWatchers (Sequence) if you want: users who want glp-1 medication combined with the weightwatchers program and community — $74 ongoing membership (on 12-month plan, $149-$299 first month) + $349 ongoing medication = $423/mo all-in.
Still undecided? Editor's #1 Overall Pick
Embody
$299/mo · 7.3/10 · Compounded
If neither Enhance MD nor WeightWatchers (Sequence) feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.
Read Full Reviews
Related comparisons
Other matchups readers comparing Enhance MD or WeightWatchers (Sequence) tend to look at next.